Smiths Medical 21-4052-24 - KIT PORT-A-CATH SINGLE LUMEN 1MM ID 1.9MM OD POLYSULFONE/TITANIUM PORT 5.8FR 76CM POLYURETHANE CATHETER STRAIGHT/BLUNT NEEDLE UNASSEMBLED

Smiths Medical 21-4052-24 - KIT PORT-A-CATH SINGLE LUMEN 1MM ID 1.9MM OD POLYSULFONE/TITANIUM PORT 5.8FR 76CM POLYURETHANE CATHETER STRAIGHT/BLUNT NEEDLE UNASSEMBLED

The Smiths Medical 21-4052-24 Port-A-Cath Kit is a high-performance implantable vascular access solution designed for reliable, long-term intravenous therapy. Built with a durable polysulfone and titanium port, this single lumen system ensures consistent access for repeated treatments while maintaining patient comfort and safety. The catheter features a 1mm internal diameter and 1.9mm outer diameter, providing efficient flow rates suitable for a wide range of infusion therapies.

This kit includes a 5.8 French, 76cm polyurethane catheter engineered for flexibility and biocompatibility. The straight, blunt needle design enhances procedural safety and minimizes the risk of vessel trauma during placement. Delivered unassembled, the system allows clinicians to prepare and customize the setup according to specific procedural needs, ensuring greater control and precision during implantation.

Ideal for oncology, long-term medication delivery, and chronic care settings, this Port-A-Cath system is trusted by healthcare professionals for its durability, performance, and ease of use in demanding clinical environments.

Key Benefits

This implantable port system is designed to support long-term vascular access while reducing the need for repeated venipuncture, improving overall patient comfort. The titanium and polysulfone construction offers excellent strength and resistance to wear, ensuring dependable performance over extended periods.

The single lumen configuration simplifies infusion management while maintaining optimal flow characteristics. Its polyurethane catheter adapts to patient anatomy, reducing irritation and supporting long-term placement. The straight and blunt needle design contributes to safer insertion, minimizing complications during access.

The unassembled format provides flexibility for clinicians, allowing customization and precise handling during procedures. This makes it suitable for a wide range of clinical applications, from chemotherapy to antibiotic therapy.

Compatibility and Applications

The Smiths Medical 21-4052-24 Port-A-Cath Kit is compatible with standard non-coring needles and infusion systems commonly used in hospital and outpatient settings. It integrates seamlessly with vascular access protocols, making it suitable for a variety of clinical environments.

This device is widely used in oncology for chemotherapy administration, as well as in long-term intravenous therapies such as parenteral nutrition, blood sampling, and antibiotic treatments. It is also appropriate for patients requiring frequent or continuous venous access, particularly in chronic disease management.

Its robust design supports use in both inpatient and ambulatory care settings, ensuring versatility across multiple treatment pathways.

Usage Guidelines

The Port-A-Cath system should be implanted by a qualified healthcare professional under sterile conditions. Proper placement involves surgical insertion of the port beneath the skin, typically in the chest area, with the catheter positioned in a central vein.

Before use, all components should be inspected for integrity and sterility. During access, clinicians should use appropriate non-coring needles to prevent damage to the port septum. Routine flushing protocols must be followed to maintain catheter patency and reduce the risk of occlusion.

Regular monitoring of the insertion site is recommended to identify any signs of infection or complications early. Following established clinical guidelines ensures optimal performance and patient safety throughout the devices lifespan.

Certifications and Safety Standards

This Port-A-Cath kit is manufactured in accordance with stringent medical device quality standards, ensuring compliance with regulatory requirements for safety and performance. The materials used, including titanium and medical-grade polyurethane, are selected for their proven biocompatibility and durability.

The device is designed to meet industry expectations for implantable vascular access systems, supporting safe use in both hospital and outpatient settings. Strict quality control measures are applied throughout the manufacturing process to ensure consistency and reliability.

Comparison with Competitors

Compared to other implantable port systems, the Smiths Medical 21-4052-24 stands out for its combination of durability and flexibility. The use of titanium in the port housing provides enhanced strength compared to plastic-only alternatives, while the polysulfone component adds resistance to chemical degradation.

The polyurethane catheter offers improved flexibility over silicone-based options, allowing better adaptation to patient anatomy and reducing the risk of kinking. Its single lumen design simplifies use and reduces maintenance complexity, making it a practical choice for many clinical applications.

The inclusion of a straight, blunt needle further differentiates this system by prioritizing safety during insertion and access procedures.

Typical User Profile and Application Scenarios

This Port-A-Cath system is commonly used by oncologists, infusion nurses, and interventional radiologists who require dependable long-term vascular access solutions. It is particularly suited for patients undergoing chemotherapy, where repeated venous access is necessary.

It is also widely used in home infusion programs and outpatient clinics, where ease of access and reliability are essential. Patients with chronic illnesses requiring frequent medication administration benefit significantly from the reduced discomfort and improved quality of life provided by implantable port systems.

The system is equally applicable in hospital settings where long-term central venous access is required for complex treatment regimens.

Best Practices for Use and Maintenance

To ensure optimal performance, the Port-A-Cath system should be accessed using only compatible non-coring needles. Routine flushing with appropriate solutions is essential to maintain catheter patency and prevent clot formation.

Healthcare providers should follow strict aseptic techniques during access and maintenance to reduce the risk of infection. Regular inspection of the port site is recommended, and any signs of redness, swelling, or discomfort should be addressed promptly.

Proper training for clinicians and adherence to institutional protocols will extend the life of the device and improve patient outcomes. When not in use, the port should be maintained according to recommended flushing schedules to preserve functionality.

Regulatory and Safety Information

This device is intended for use by trained healthcare professionals in controlled clinical environments. It should be used in accordance with all applicable medical guidelines and institutional protocols.

Patients should be informed about the purpose of the device, potential risks, and signs of complications. Proper documentation and monitoring are essential to ensure safe and effective use over time.

Any adverse events or device-related concerns should be reported and managed in line with established regulatory requirements. The device should not be reused or re-sterilized, and all components must be handled according to manufacturer instructions.

How to Order

To place an order for the Smiths Medical 21-4052-24 Port-A-Cath Kit, please contact CIA Medicals customer service team. Our representatives are available to assist with product details, bulk purchasing options, and delivery timelines.

Call (312) 275-5850 to speak directly with a product specialist and ensure you receive the right solution for your clinical needs.